BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18

Benzinga Newsdesk www.benzinga.com Positive 78.9%

Neg 0% Neu 0% Pos 78.9%

BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $16 to $18.